RE:RE:From the April NewsletterExcept that Theralase announced in the newsletter it would be compiling 450 day data on the first 20 - 25 patients. 450 days is exactly 90 days after 360 days so it sounds to me like Theralase is saying the submission will occur 360 days after the first 90 day assessment of patient 25, or 450 days after the initial treatment of patient 25.
Johnandrose22 wrote: I would think that Phase 1 patients 5 and 6 would cover the long range of this interim data, ie 450 days. Perhaps that is why the company highlighted their extraordinary CRs in consistent news releases.
Good news continues to build.
John